Squarepoint
ETON icon

Squarepoint’s Eton Pharmaceutcials ETON Stock Holding History

Squarepoint’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,482
Closed -$228K – 4445
2025
Q4 		$228K Sell
13,482
-46,163
-77% -$812K ﹤0.01% 3789
2025
Q3 		$1.3M Sell
59,645
-34,151
-36% -$567K ﹤0.01% 2458
2025
Q2 		$1.34M Buy
93,796
+29,001
+45% +$458K ﹤0.01% 2408
2025
Q1 		$841K Buy
+64,795
New +$979K ﹤0.01% 2816
2024
Q3 		– Sell
-41,255
Closed -$136K – 4253
2024
Q2 		$136K Sell
41,255
-7,838
-16% -$27.4K ﹤0.01% 3746
2024
Q1 		$184K Sell
49,093
-14,331
-23% -$62.6K ﹤0.01% 3635
2023
Q4 		$278K Buy
63,424
+18,782
+42% +$75.3K ﹤0.01% 3408
2023
Q3 		$186K Buy
44,642
+30,609
+218% +$118K ﹤0.01% 3433
2023
Q2 		$49K Buy
+14,033
New +$51.6K ﹤0.01% 3442
2020
Q3 		– Sell
-33,126
Closed -$181K – 2572
2020
Q2 		$181K Buy
+33,126
New +$165K ﹤0.01% 1846

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Squarepoint's ETON Position: Q1 2026 in Review

Squarepoint sold out of Eton Pharmaceutcials (ETON) in Q1 2026, closing a stake of 13,482 shares — an estimated $228K sold.

Squarepoint first reported a position in ETON in Q2 2020 and held it in 10 quarters. The position peaked at $1.34M in Q2 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Squarepoint reported no remaining Eton Pharmaceutcials position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 13,482 Eton Pharmaceutcials shares in Q1 2026, an estimated $228K.
  • Squarepoint first reported a position in Eton Pharmaceutcials in Q2 2020 and held it in 10 quarters.
  • Squarepoint's Eton Pharmaceutcials position peaked at $1.34M in Q2 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.